ER-phagy

ER-phagy (Reticulophagy) 是内质网部分区域被溶酶体降解的过程,参与调控肿瘤细胞的各个发展阶段,并有助于恢复细胞稳态或促使细胞凋亡。ER-phagy 通过包括未折叠蛋白反应、BCL-2 家族蛋白和 Caspase 通路等多种机制,分别调节肿瘤发生和维持肿瘤细胞稳态。

ER-phagy (Reticulophagy) is the process by which some regions of the endoplasmic reticulum are degraded by lysosomes. It participates in regulating various stages of tumor cell development and helps to restore cell homeostasis or induce cell apoptosis. ER-phagy regulates tumorigenesis and maintains tumor cell homeostasis through multiple mechanisms including the unfolded protein response, BCL-2 family proteins, and the Caspase pathway.

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
ICD inducer-1

ICD inducer-1(Compound Re1)是一种有效的免疫原性细胞死亡(ICD)诱导剂,可靶向内质网(ER)并在后期阻断ER吞噬,有望用于癌症的研究。

ICD inducer-1
Pt(II)-NHC complex 2C
Platinum(II)-N-heterocyclic carbene complex 2C

Pt(II)-NHC Complex 2C(Platinum(II)-N-Heterocyclic carbene complex 2C,Compound 2C)是一种基于 N-杂环卡宾 (NHC) 的铂 (II) 配合物,作为免疫原性细胞死亡 (ICD) 诱导剂,可诱导肝癌细胞内质网应激 (ERS) 并产生 ROS,最终导致损伤相关分子模式 (DAMP) 的释放,同时将细胞周期阻滞在 S 期并显著诱导细胞凋亡 (apoptosis),在小鼠模型中显示出抗肝癌潜力,并在肝损伤模型中激活了免疫细胞。

3035433-94-1
Pt(II)-NHC complex 2C

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础